Quarterly report [Sections 13 or 15(d)]

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

v3.25.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional
Paid-in
Capital
Accumulated
Deficit
Beginning balance (in shares) at Dec. 31, 2023   8,311,237    
Beginning balance at Dec. 31, 2023 $ 15,273 $ 1 $ 318,600 $ (303,328)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted stock units, net (in shares)   126,305    
Stock-based compensation (670)   (670)  
Net loss (24,050)     (24,050)
Ending balance (in shares) at Mar. 31, 2024   8,437,542    
Ending balance at Mar. 31, 2024 $ (9,447) $ 1 317,930 (327,378)
Beginning balance (in shares) at Dec. 31, 2024 8,656,122 8,656,122    
Beginning balance at Dec. 31, 2024 $ (100,500) $ 1 322,729 (423,230)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock for PIPE Investment (in shares)   1,771,586    
Issuance of common stock for PIPE Investment 3,477   3,477  
Deemed dividend to Series A Preferred Stock (403)   (403)  
Vesting of restricted stock units, net (in shares)   215,260    
Stock-based compensation 647   647  
Net loss $ (37,675)     (37,675)
Ending balance (in shares) at Mar. 31, 2025 10,642,968 10,642,968    
Ending balance at Mar. 31, 2025 $ (134,454) $ 1 $ 326,450 $ (460,905)